Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Andria L Del Tredici"'
Autor:
Hua Fang, Xiequn Xu, Kulvinder Kaur, Matthew Dedek, Guang-dan Zhu, Bae J. Riley, Frank G. Espin, Andria L. Del Tredici, Tanya A. Moreno
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Purpose:HLA-B∗15:02 is strongly associated with life-threatening severe skin hypersensitivity reactions in patients treated with carbamazepine (CBZ) and structurally related medications. FDA-approved labeling recommends HLA-B∗15:02 screening befo
Externí odkaz:
https://doaj.org/article/63105fec94a04c3db4e6542ead2950d1
Autor:
Andria L. Del Tredici, Alka Malhotra, Matthew Dedek, Frank Espin, Dan Roach, Guang-dan Zhu, Joseph Voland, Tanya A. Moreno
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
The CYP2D6 gene encodes an enzyme important in the metabolism of many commonly used medications. Variation in CYP2D6 is associated with inter-individual differences in medication response, and genetic testing is used to optimize medication therapy. T
Externí odkaz:
https://doaj.org/article/f9f5843a4af04f8092783aec5fa9bbe7
Autor:
Edmund V. Capparelli, Andria L Del Tredici, Leah LaRue, Angela Huskey, Guangdan Zhu, Penn Whitley, Eric Dawson, Brandon Adkins
Publikováno v:
The Pharmacogenomics Journal. 22:25-32
Urine drug testing (UDT) is a tool for monitoring drug use, including oxycodone. While variation in cytochrome P450 (CYP) genes is known to alter oxycodone metabolism, its impact on UDT results of oxycodone and its metabolites has not been well-studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd53885691f112c26df9d4e88e2ae92
https://doi.org/10.1038/s41397-021-00253-5
https://doi.org/10.1038/s41397-021-00253-5
Autor:
Michelle Whirl-Carrillo, Reynold C. Ly, R.H.N. van Schaik, Ann M. Moyer, Andrea Gaedigk, Lisa V. Kalman, Andria L. Del Tredici, Stuart A. Scott, Larisa H. Cavallari, Houda Hachad, Yuan Ji, Victoria M. Pratt, Karen E. Weck
Publikováno v:
The Journal of Molecular Diagnostics. 23:1047-1064
The goals of the Association for Molecular Pathology Clinical Practice Committee's Pharmacogenomics (PGx) Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing, and to determine a minimal set of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91cb1d930037b0edb0b5d4a902a61025
https://doi.org/10.1016/j.jmoldx.2021.05.013
https://doi.org/10.1016/j.jmoldx.2021.05.013
Publikováno v:
Pharmacogenomics and Personalized Medicine. 13:405-414
Background Genetic variants in the BCHE (butyrylcholinesterase) gene are associated with reduced BChE enzyme activity and prolonged post-succinylcholine neuromuscular blockade, which can lead to postanesthetic apnea and respiratory depression. Testin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::356e4165b1ca1c30ec2077f13ca40532
https://doi.org/10.2147/pgpm.s263741
https://doi.org/10.2147/pgpm.s263741
Autor:
Michelle Whirl-Carrillo, Stuart A. Scott, Larisa H. Cavallari, Karen E. Weck, Ann M. Moyer, Yuan Ji, Victoria M. Pratt, Lisa V. Kalman, Andria L. Del Tredici, Reynold C. Ly, Houda Hachad
Publikováno v:
The Journal of Molecular Diagnostics. 22:847-859
The goal of the Association for Molecular Pathology (AMP) Clinical Practice Committee's AMP Pharmacogenomics (PGx) Working Group is to define the key attributes of PGx alleles recommended for clinical testing and a minimum set of variants that should
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54023a14bac193458aed914779d89777
https://doi.org/10.1016/j.jmoldx.2020.04.204
https://doi.org/10.1016/j.jmoldx.2020.04.204
Autor:
Katrin Sangkuhl, Karla Claudio‐Campos, Larisa H. Cavallari, Jose A.G. Agundez, Michelle Whirl‐Carrillo, Jorge Duconge, Andria L. Del Tredici, Mia Wadelius, Mariana Rodrigues Botton, Erica L. Woodahl, Stuart A. Scott, Teri E. Klein, Victoria M. Pratt, Ann K. Daly, Andrea Gaedigk
Publikováno v:
Clin Pharmacol Ther
The Pharmacogene Variation Consortium (PharmVar) catalogues star (*) allele nomenclature for the polymorphic human CYP2C9 gene. Genetic variation within the CYP2C9 gene locus impacts the metabolism or bioactivation of many clinically important drugs,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e824cb642ba72030b84d266d0360f8f2
https://europepmc.org/articles/PMC8607432/
https://europepmc.org/articles/PMC8607432/
Publikováno v:
Journal of Laboratory Medicine. 43:283-286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d2cf47bd9bc2edfa9686b2f9b7a24fe
https://doi.org/10.1515/labmed-2019-0087
https://doi.org/10.1515/labmed-2019-0087
Autor:
Ann M. Moyer, Stuart A. Scott, Michelle Whirl-Carrillo, Larisa H. Cavallari, Houda Hachad, Andria L. Del Tredici, Victoria M. Pratt, Yuan Ji, Karen E. Weck
Publikováno v:
The Journal of Molecular Diagnostics. 21:746-755
The goals of the Association for Molecular Pathology Pharmacogenomics (PGx) Working Group of the Association for Molecular Pathology Clinical Practice Committee are to define the key attributes of PGx alleles recommended for clinical testing and a mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::834d37193c357020b49994c53f42a282
https://doi.org/10.1016/j.jmoldx.2019.04.003
https://doi.org/10.1016/j.jmoldx.2019.04.003
Autor:
Victoria M, Pratt, Larisa H, Cavallari, Andria L, Del Tredici, Andrea, Gaedigk, Houda, Hachad, Yuan, Ji, Lisa V, Kalman, Reynold C, Ly, Ann M, Moyer, Stuart A, Scott, R H N, van Schaik, Michelle, Whirl-Carrillo, Karen E, Weck
Publikováno v:
J Mol Diagn
The goals of the Association for Molecular Pathology Clinical Practice Committee's Pharmacogenomics (PGx) Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing, and to determine a minimal set of va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccd5089503631095fda0dbbd1cc9acd0
https://pubmed.ncbi.nlm.nih.gov/34118403
https://pubmed.ncbi.nlm.nih.gov/34118403